Identification of MicroRNAs (miRNAs) in Fecal Samples as Biomarkers for Gastroenterological Cancers
AssigneeBaylor Research Institute
InventorsAjay Goel, C. Richard Boland, Alexander Link, Francesc Balaguer
Life of this patent
Estimating the term…
Loading patent…
AssigneeBaylor Research Institute
InventorsAjay Goel, C. Richard Boland, Alexander Link, Francesc Balaguer
Estimating the term…
A simple, rapid, inexpensive, and promising commercial biomarker assay method for multiple diseases is described herein. The present invention detects miRNA-based biomarkers in human stool specimens. The method of the present invention amplifies miRNA directly from stool specimens without any prior miRNA extraction. Differential expression of specific microRNAs in stool of colorectal cancer CRC and adenoma patients suggest fecal microRNAs as a novel potential biomarker for colorectal neoplasia detection. The method of the present invention has diagnostic, prognostic, and therapeutic relevance for gastroenterological cancers/colorectal cancer and as well as further acquired or hereditary GI diseases.
A method of isolating and amplifying one or more micro RNAs (miRNAs) from a biological sample comprising the steps of:
A method of detecting a disease in a subject suspected of having the disease comprising the steps of:
A method of isolating and amplifying one or more microRNAs (miRNAs) from a stool sample comprising the steps of:
A method of detecting a colorectal or a gastroenterological cancer in one or more subjects comprising the steps of:
A method of processing a biological sample for amplification of one more target MicroRNAs (miRNAs) in the sample without a prior extraction of the one or more miRNAs comprising the steps of:
Dependencies are inferred from the claim text.